Perspective Therapeutics (CATX) Work In Process (2011 - 2023)
Perspective Therapeutics' (CATX) quarterly Work In Process came in at $616000.0 in Q1 2023, up 73.52% year-over-year from $355000.0 in Q1 2022, and down 3.14% quarter-over-quarter from $636000.0 in Q4 2022.
Analysis
Perspective Therapeutics (CATX) Work In Process (2011 - 2023) Analysis & Trends
Perspective Therapeutics has disclosed Work In Process across 11 years of filings, most recently posting $616000.0 for Q1 2023.
- In Q1 2023, Work In Process rose 73.52% year-over-year to $616000.0; the TTM figure through Mar 2023 stood at $616000.0 (up 73.52% YoY), while the FY2022 annual figure was $636000.0, changed N/A from the prior year.
- Work In Process came in at $616000.0 for Q1 2023 at Perspective Therapeutics, down from $636000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $636000.0 in Q4 2022 to a low of $114000.0 in Q1 2019.
- Average Work In Process over 5 years is $306000.0, with a median of $240000.0 recorded in 2020.
- Year-over-year, Work In Process decreased 25.49% in 2019 and soared 129.1% in 2022.
- Over 5 years, Work In Process stood at $166000.0 in 2019, then climbed by 26.51% to $210000.0 in 2020, then soared by 37.14% to $288000.0 in 2021, then jumped by 120.83% to $636000.0 in 2022, then declined by 3.14% to $616000.0 in 2023.
- Per Business Quant data, the three most recent Work In Process figures were $616000.0 in Q1 2023, $636000.0 in Q4 2022, and $614000.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Perspective Therapeutics | 358.23 Mn | 358.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 616,000.00 |
| Dec 31, 2022 | 636,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 462,000.00 |
| Mar 31, 2022 | 355,000.00 |
| Dec 31, 2021 | 288,000.00 |
| Sep 30, 2021 | 268,000.00 |
| Jun 30, 2021 | 286,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Dec 31, 2020 | 210,000.00 |
| Sep 30, 2020 | 240,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Mar 31, 2020 | 198,000.00 |
| Dec 31, 2019 | 166,000.00 |
| Sep 30, 2019 | 161,000.00 |
| Jun 30, 2019 | 166,000.00 |
| Mar 31, 2019 | 114,000.00 |
| Dec 31, 2018 | 97,000.00 |
| Sep 30, 2018 | 102,000.00 |
| Jun 30, 2018 | 96,000.00 |